product summary
company name :
BioVision
product type :
antibody
product name :
Cathepsin B Antibody
catalog :
3190-100
conjugate :
nonconjugated
reactivity :
human, mouse
application :
immunohistochemistry, immunocytochemistry
more info or order :
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; mouse; 1:25; loading ...; fig s6a
Naeem A, Tommasi C, Cole C, Brown S, Zhu Y, Way B, et al. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic d. J Allergy Clin Immunol. 2017;139:1228-1241 pubmed publisher
  • immunocytochemistry; human; 1:100
Zhang J, He L, Geng X, Firestone R, Hong Y, Li Y. Anti-cancer effects of novel doxorubicin prodrug PDOX in MCF-7 breast cancer cells. J Huazhong Univ Sci Technolog Med Sci. 2014;34:521-528 pubmed publisher
company information
BioVision
980 Linda Vista Avenue
Mountain View, California 94043
support@biovision.com
http://www.biovision.com
1-650-428-0236
headquarters: USA
BioVision, Inc., a privately held company headquartered in the beautiful San Francisco Bay area, specializes in developing and manufacturing research products for molecular and cell biologists. BioVision offers a wide variety of products including reagents, bioassay kits, antibodies, recombinant proteins, and other research tools for studying apoptosis, cell signaling pathways, cell proliferation, metabolism, cellular stress, cell damage and repair, cholesterol and obesity, Protein A/G/L, multi-color fluorescence proteins and gene regulation, etc. BioVision’s products are currently being sold in more than 60 countries worldwide.